CRA provided expert reports and trial testimony in trade secret litigation concerning an early-stage oncology product candidate. Plaintiff claimed that the alleged misappropriation led to accelerated development of a competing potential treatment. CRA quantified unjust enrichment using a methodology that measured the value associated with accelerated development, recognizing advantages associated with early versus late entry into the marketplace.
Econometrics for Intellectual Property disputes
What is econometrics? Econometrics is the application of statistical methods to economic and financial data, utilized for quantifying and rebutting economic...